Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry

Keyphrases

• Elderly Patients 100%
• Patient Data 100%
• Ticagrelor 100%
• Dual Antiplatelet Therapy 100%
• Net Clinical Benefit 100%
• Myocardial Infarction 66%
• Clopidogrel 50%
• Acute Coronary Syndrome 50%
• Neutral Effects 50%
• Bleeding 33%
• Percutaneous Coronary Intervention 33%
• Bleeding Risk 33%
• All-cause Mortality 33%
• Bleeding Academic Research Consortium 33%
• Low Risk 16%
• Major Bleeding 16%
• Aspirin 16%
• Adverse Cardiac Events 16%
• Prasugrel 16%
• Risk Reduction 16%
• P2Y12 Inhibitors 16%
• Decreased Risk 16%
• 85-year-old 16%
• Sensitivity Analysis 16%
• Super-elderly Patient 16%
• Net Adverse Clinical Events 16%
• Inverse Probability of Treatment Weighting 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Ticagrelor 100%
• Antiplatelet 100%
• Heart Infarction 66%
• Clopidogrel 50%
• Acute Coronary Syndrome 50%
• Bleeding 33%
• All Cause Mortality 33%
• Prasugrel 16%
• Acetylsalicylic Acid 16%